• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型“微纳复合”结构干粉吸入器系统的物理化学稳定性及空气动力学性质研究

Investigation of Physico-Chemical Stability and Aerodynamic Properties of Novel "Nano-in-Micro" Structured Dry Powder Inhaler System.

作者信息

Party Petra, Ambrus Rita

机构信息

Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös Street 6, 6720 Szeged, Hungary.

出版信息

Micromachines (Basel). 2023 Jun 30;14(7):1348. doi: 10.3390/mi14071348.

DOI:10.3390/mi14071348
PMID:37512657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10386112/
Abstract

Pulmonary drug transport has numerous benefits. Large surface areas for absorption and limited drug degradation of the gastrointestinal system are provided through the respiratory tract. The administration is painless and easy for the patient. Due to their better stability when compared to liquid formulations, powders have gained popularity among pulmonary formulations. In the pharmaceutical sector, quality assurance and product stability have drawn a lot of attention. Due to this, it was decided to perform a long-term stability study on a previously developed, nanosized dry powder inhaler (DPI) formulation that contained meloxicam. Wet milling was implemented to reduce the particle size, and nano spray-drying was used to produce the extra-fine inhalable particles. The particle diameter was determined using dynamic light scattering and laser diffraction. Scanning electron microscopy was utilized to describe the morphology. X-ray powder diffraction and differential scanning calorimetry were applied to determine the crystallinity. In an artificial lung medium, the in vitro dissolution was studied. The Andersen Cascade Impactor was used to investigate the in vitro aerodynamic characteristics. The stability test results demonstrated that the DPI formulation maintained its essential qualities after 6 and 12 months of storage. Consequently, the product might be promising for further studies and development.

摘要

肺部药物输送有诸多益处。呼吸道提供了用于吸收的大表面积以及胃肠道系统中有限的药物降解。给药对患者而言无痛且简便。与液体制剂相比,粉末制剂稳定性更佳,因而在肺部制剂中颇受青睐。在制药领域,质量保证和产品稳定性备受关注。因此,决定对先前研发的含美洛昔康的纳米级干粉吸入剂(DPI)制剂开展长期稳定性研究。采用湿磨法降低粒径,并使用纳米喷雾干燥法制备超细微可吸入颗粒。通过动态光散射和激光衍射测定粒径。利用扫描电子显微镜描述形态。应用X射线粉末衍射和差示扫描量热法测定结晶度。在人工肺介质中研究体外溶出度。使用安德森级联撞击器研究体外空气动力学特性。稳定性测试结果表明,DPI制剂在储存6个月和12个月后仍保持其基本品质。因此,该产品有望用于进一步的研究和开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/9c0f5270ae62/micromachines-14-01348-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/978af6421b47/micromachines-14-01348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/f979c0d92d37/micromachines-14-01348-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/2f740ab58a91/micromachines-14-01348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/c304814a4fb0/micromachines-14-01348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/e55eb811fc0b/micromachines-14-01348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/9c0f5270ae62/micromachines-14-01348-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/978af6421b47/micromachines-14-01348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/f979c0d92d37/micromachines-14-01348-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/2f740ab58a91/micromachines-14-01348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/c304814a4fb0/micromachines-14-01348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/e55eb811fc0b/micromachines-14-01348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e0f/10386112/9c0f5270ae62/micromachines-14-01348-g006.jpg

相似文献

1
Investigation of Physico-Chemical Stability and Aerodynamic Properties of Novel "Nano-in-Micro" Structured Dry Powder Inhaler System.新型“微纳复合”结构干粉吸入器系统的物理化学稳定性及空气动力学性质研究
Micromachines (Basel). 2023 Jun 30;14(7):1348. doi: 10.3390/mi14071348.
2
Development of extra-fine particles containing nanosized meloxicam for deep pulmonary delivery: In vitro aerodynamic and cell line measurements.开发含纳米美洛昔康的超细颗粒用于肺部深部递送:体外空气动力学和细胞系测量。
Eur J Pharm Sci. 2022 Sep 1;176:106247. doi: 10.1016/j.ejps.2022.106247. Epub 2022 Jun 25.
3
Formulation and In Vitro and In Silico Characterization of "Nano-in-Micro" Dry Powder Inhalers Containing Meloxicam.含美洛昔康的“微纳”干粉吸入剂的制剂及其体外和计算机模拟表征
Pharmaceutics. 2021 Feb 3;13(2):211. doi: 10.3390/pharmaceutics13020211.
4
Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery.用于肺部给药的含布洛芬纳米包埋微粒的制备与表征
Pharmaceutics. 2023 Feb 6;15(2):545. doi: 10.3390/pharmaceutics15020545.
5
[Stability testing of meloxicam-containing microcomposites for inhalation].[含美洛昔康的吸入用微复合材料的稳定性测试]
Acta Pharm Hung. 2014;84(2):55-62.
6
Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.含盐酸环丙沙星的干粉吸入系统的物理化学稳定性和雾化性能。
J Pharm Biomed Anal. 2018 Jan 30;148:73-79. doi: 10.1016/j.jpba.2017.09.019. Epub 2017 Sep 22.
7
Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties.新型抗生素干粉吸入剂制剂,采用联合技术改善空气动力学性能。
Eur J Pharm Sci. 2018 Oct 15;123:20-27. doi: 10.1016/j.ejps.2018.07.030. Epub 2018 Jul 17.
8
Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.用于递送酒石酸氢卡巴拉汀的新型干粉吸入制剂的研发。
Int J Pharm. 2016 Mar 30;501(1-2):124-38. doi: 10.1016/j.ijpharm.2016.01.066. Epub 2016 Feb 1.
9
Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.设计、物理化学特性分析和优化有机溶液高级喷雾干燥二棕榈酰磷脂酰胆碱(DPPC)和二棕榈酰磷脂酰乙醇胺聚乙二醇(DPPE-PEG)微米和纳米粒子,用于作为干粉吸入剂气溶胶的靶向呼吸纳米医学递药。
Int J Nanomedicine. 2013;8:275-93. doi: 10.2147/IJN.S30724. Epub 2013 Jan 15.
10
Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols.纳米喷雾干燥的吡嗪酰胺-L-亮氨酸干粉、物理性质及用作干粉气雾剂的可行性
Pharm Dev Technol. 2016;21(1):68-75. doi: 10.3109/10837450.2014.971373. Epub 2014 Oct 21.

引用本文的文献

1
Development of Mannitol-Based Microparticles for Dry Powder Inhalers: Enhancing Pulmonary Delivery of NSAIDs.用于干粉吸入器的基于甘露醇的微粒的开发:增强非甾体抗炎药的肺部递送。
Pharmaceuticals (Basel). 2025 Jun 19;18(6):923. doi: 10.3390/ph18060923.
2
Nanoparticle-Based Dry Powder Inhaler Containing Ciprofloxacin for Enhanced Targeted Antibacterial Therapy.含环丙沙星的纳米颗粒干粉吸入器用于增强靶向抗菌治疗
Pharmaceutics. 2025 Apr 7;17(4):486. doi: 10.3390/pharmaceutics17040486.
3
Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine.

本文引用的文献

1
Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery.用于肺部给药的含布洛芬纳米包埋微粒的制备与表征
Pharmaceutics. 2023 Feb 6;15(2):545. doi: 10.3390/pharmaceutics15020545.
2
On the Physical Stability of Leucine-Containing Spray-Dried Powders for Respiratory Drug Delivery.用于呼吸道药物递送的含亮氨酸喷雾干燥粉末的物理稳定性
Pharmaceutics. 2023 Jan 28;15(2):435. doi: 10.3390/pharmaceutics15020435.
3
Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions.
吸入疗法中基于纳米颗粒的药物递送系统:改善呼吸医学。
Pharmaceuticals (Basel). 2024 Aug 12;17(8):1059. doi: 10.3390/ph17081059.
高应力条件下吸入用载环丙沙星聚(2-乙基-2-恶唑啉)纳米颗粒干粉吸入剂配方的稳定性
Pharmaceuticals (Basel). 2022 Oct 2;15(10):1223. doi: 10.3390/ph15101223.
4
Spray drying and nano spray drying as manufacturing methods of drug-loaded polymeric particles.喷雾干燥和纳米喷雾干燥作为载药聚合物颗粒的制造方法。
Polim Med. 2022 Jul-Dec;52(2):101-111. doi: 10.17219/pim/152230.
5
Development of extra-fine particles containing nanosized meloxicam for deep pulmonary delivery: In vitro aerodynamic and cell line measurements.开发含纳米美洛昔康的超细颗粒用于肺部深部递送:体外空气动力学和细胞系测量。
Eur J Pharm Sci. 2022 Sep 1;176:106247. doi: 10.1016/j.ejps.2022.106247. Epub 2022 Jun 25.
6
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches.肺部给药纳米药物以规避生理屏障:策略和表征方法。
Adv Drug Deliv Rev. 2022 Jun;185:114309. doi: 10.1016/j.addr.2022.114309. Epub 2022 Apr 22.
7
Particle engineering in dry powders for inhalation.用于吸入的干粉中的颗粒工程。
Eur J Pharm Sci. 2022 May 1;172:106158. doi: 10.1016/j.ejps.2022.106158. Epub 2022 Mar 4.
8
Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis.从计量吸入器切换至干粉吸入器对气候排放物和哮喘控制的影响:事后分析。
Thorax. 2022 Dec;77(12):1187-1192. doi: 10.1136/thoraxjnl-2021-218088. Epub 2022 Feb 7.
9
Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations.吸入疗法对小气道的靶向作用:纳米亮氨酸载体制剂
Pharmaceutics. 2021 Nov 3;13(11):1855. doi: 10.3390/pharmaceutics13111855.
10
Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections.纳米颗粒介导的肺部药物传递:实现高效治疗耐药性呼吸道细菌感染的最新进展。
Drug Deliv Transl Res. 2021 Aug;11(4):1634-1654. doi: 10.1007/s13346-021-00954-1. Epub 2021 Mar 10.